BeyondSpring Inc. Accrued Liabilities, Current
BeyondSpring Inc. (BYSI) had Accrued Liabilities, Current of $1.39 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $1.39M.
- 2026-03-31: Accrued Liabilities, Current $1.28M.
- 2025-12-31: Accrued Liabilities, Current $938.00K.
- 2025-09-30: Accrued Liabilities, Current $990.00K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.39M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $938.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $990.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $926.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $909.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $840.00K 10-K · filed 2026-03-25 | |
| 2024-06-30 | $1.77M 6-K · filed 2024-08-29 | |
| 2023-12-31 | $2.35M 10-K · filed 2025-03-27 | $2.58M 6-K · filed 2024-08-29 |
| 2023-06-30 | $1.68M 6-K · filed 2024-02-02 | |
| 2022-12-31 | $2.47M 6-K · filed 2024-02-02 | |
| 2022-06-30 | $2.70M 6-K · filed 2023-02-28 | |
| 2021-12-31 | $3.86M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $7.19M 6-K · filed 2021-12-30 | |
| 2021-06-30 | $7.21M 6-K · filed 2021-09-10 | |
| 2021-03-31 | $5.76M 6-K · filed 2021-06-16 | |
| 2020-12-31 | $5.61M 20-F · filed 2022-04-14 | |
| 2020-09-30 | $8.38M 6-K · filed 2020-11-17 | |
| 2020-06-30 | $7.19M 6-K · filed 2020-09-03 | |
| 2020-03-31 | $4.70M 6-K · filed 2020-06-11 | |
| 2019-12-31 | $5.86M 20-F · filed 2021-04-30 | |
| 2019-09-30 | $4.79M 6-K · filed 2019-12-18 | |
| 2019-06-30 | $6.08M 6-K · filed 2019-09-18 | |
| 2019-03-31 | $7.87M 6-K · filed 2019-07-10 | |
| 2018-12-31 | $5.50M 20-F · filed 2020-04-30 | |
| 2018-06-30 | $2.33M 6-K · filed 2018-10-23 | |
| 2018-03-31 | $1.11M 6-K · filed 2018-06-21 | |
| 2017-12-31 | $807.00K 20-F · filed 2019-04-30 | |
| 2017-09-30 | $1.32M 6-K · filed 2017-11-09 | |
| 2017-06-30 | $584.00K 6-K · filed 2017-08-21 | |
| 2017-03-31 | $459.00K 6-K · filed 2017-05-22 | |
| 2016-12-31 | $1.43M 20-F · filed 2018-04-03 | |
| 2015-12-31 | $210.00K 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |